Licensing & Ventures Group

Ceres Nanosciences, Inc.

Year Founded: 2009

Ross Dunlap

Ceres Nanosciences Inc. is engaged in the research, development, and commercialization of innovative sample preparation products and diagnostic tests, based on its proprietary Nanotrap® particle platform. The Nanotrap® particles capture, enrich and preserve the most valuable biomarkers, enabling early and accurate detection of diseases such as cancer, cardiac, neurological, and infectious diseases, resulting in improved patient outcomes and reduced health care costs. 

Founded in 2009 by UVA alumnus Ross Dunlap, the company is headquartered in Manassas, VA and is the only UVA alumni company in the LVG Seed Fund portfolio. In June 2019, a collaborative team from Ceres, UVA, and George Mason University received a $600,000 Virginia Catalyst award for the development of a Nanotrap® liquid biopsy collection device to be matched by $1.2 million in product development funding by Ceres.